Murray Stahl's PFE Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 67,671 shares of Pfizer Inc. (PFE) worth $1.69 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Murray Stahl has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2024, adding 36,370 shares. Largest reduction occurred in Q3 2025, reducing 32,357 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -3,155 | Reduce 4.45% | 67,671 | $24.90 |
| Q3 2025 | -32,357 | Reduce 31.36% | 70,826 | $25.48 |
| Q2 2025 | +3,157 | Add 3.16% | 103,183 | $24.24 |
| Q1 2025 | -677 | Reduce 0.67% | 100,026 | $25.34 |
| Q4 2024 | +6,888 | Add 7.34% | 100,703 | $26.53 |
| Q3 2024 | +36,370 | Add 63.31% | 93,815 | $28.94 |
| Q2 2024 | +300 | Add 0.52% | 57,445 | $27.98 |
| Q1 2024 | +6,979 | Add 13.91% | 57,145 | $27.75 |
| Q4 2023 | -255 | Reduce 0.51% | 50,166 | $28.79 |
| Q3 2023 | +1,850 | Add 3.81% | 50,421 | $33.17 |
| Q2 2023 | +209 | Add 0.43% | 48,571 | $36.68 |
| Q1 2023 | -2,550 | Reduce 5.01% | 48,362 | $40.80 |
| Q3 2022 | -654 | Reduce 1.27% | 50,912 | $43.76 |
| Q2 2022 | -1,940 | Reduce 3.63% | 51,566 | $52.44 |
| Q4 2021 | +189 | Add 0.35% | 53,506 | $59.06 |
| Q3 2021 | -1,100 | Reduce 2.02% | 53,317 | $43.01 |
| Q2 2021 | -3,268 | Reduce 5.67% | 54,417 | $39.16 |
| Q1 2021 | +2,253 | Add 4.06% | 57,685 | $36.23 |
| Q4 2020 | -7,625 | Reduce 12.09% | 55,432 | $36.80 |
| Q3 2020 | +1,575 | Add 2.56% | 63,057 | $36.70 |
| Q2 2020 | -3,743 | Reduce 5.74% | 61,482 | $32.69 |
| Q1 2020 | +1,193 | Add 1.86% | 65,225 | $32.64 |
| Q4 2019 | +1,958 | Add 3.15% | 64,032 | $39.18 |
| Q3 2019 | -3,297 | Reduce 5.04% | 62,074 | $35.92 |
| Q2 2019 | -1,138 | Reduce 1.71% | 65,371 | $43.32 |
| Q1 2019 | -100 | Reduce 0.15% | 66,509 | $42.48 |
| Q4 2018 | +646 | Add 0.98% | 66,609 | $43.64 |
| Q3 2018 | -4,050 | Reduce 5.78% | 65,963 | $44.07 |
| Q2 2018 | -3,354 | Reduce 4.57% | 70,013 | $36.28 |
| Q1 2018 | -1,589 | Reduce 2.12% | 73,367 | $35.49 |
| Q3 2017 | +980 | Add 1.32% | 74,956 | $35.70 |
| Q2 2017 | +3,894 | Add 5.56% | 73,976 | $33.59 |
| Q1 2017 | +682 | Add 0.98% | 70,082 | $34.20 |
| Q4 2016 | +3,518 | Add 5.34% | 69,400 | $32.48 |
| Q3 2016 | -2,373 | Reduce 3.48% | 65,882 | $33.86 |
| Q2 2016 | -217 | Reduce 0.32% | 68,255 | $35.22 |
| Q1 2016 | +2,531 | Add 3.84% | 68,472 | $29.63 |
| Q4 2015 | +200 | Add 0.30% | 65,941 | $32.29 |
| Q3 2015 | +2,965 | Add 4.72% | 65,741 | $31.41 |
| Q2 2015 | +2,030 | Add 3.34% | 62,776 | $33.52 |
| Q1 2015 | -3,309 | Reduce 5.17% | 60,746 | $34.78 |
| Q4 2014 | +1,027 | Add 1.63% | 64,055 | $31.15 |
| Q3 2014 | +67 | Add 0.11% | 63,028 | $29.57 |
| Q2 2014 | +106 | Add 0.17% | 62,961 | $29.67 |
| Q1 2014 | +1,250 | Add 2.03% | 62,855 | $32.12 |
| Q4 2013 | +2,940 | Add 5.01% | 61,605 | $30.63 |
| Q3 2013 | -215 | Reduce 0.37% | 58,665 | $28.72 |
| Q2 2013 | +58,881 | Add 0.00% | 58,880 | $28.01 |
Murray Stahl's Pfizer Investment FAQs
Murray Stahl first purchased Pfizer Inc. (PFE) in Q2 2013, acquiring 58,880 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held Pfizer Inc. (PFE) for 51 quarters since Q2 2013.
Murray Stahl's largest addition to Pfizer Inc. (PFE) was in Q2 2013, adding 58,880 shares worth $1.65 M.
According to the latest 13F filing for Q4 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 67,671 shares of Pfizer Inc. (PFE), valued at approximately $1.69 M.
As of the Q4 2025 filing, Pfizer Inc. (PFE) represents approximately 0.02% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in Pfizer Inc. (PFE) was 103,183 shares, as reported at the end of Q2 2025.